Literature DB >> 25991272

How much does hyperkalemia lengthen inpatient stays? About methodological issues in analyzing time-dependant events.

Emmanuel Chazard1, Choé Dumesnil1, Régis Beuscart1.   

Abstract

Adverse events may increase the hospital length of stay (LOS). As a consequence, computing the mean difference of LOS between two inpatient groups, with or without event, is a convenient way to evaluate their severity. Conversely, some adverse events are time-dependent: this leads to overestimate the consequences of the adverse event when statistical tests are performed. In this paper, we interest on hyperkalemia in the inpatient database of a community hospital (2% of the inpatient stays). The cumulated risk of hyperkalemia appears to be a linear function of the LOS. We compute the LOS difference associated with hyperkalemia by using 17 statistical methods. The raw LOS difference is 8.8 days, but the simulation finds a difference of 2.3 days, while the regressions (with linear or log link, with or without pairing, with or without propensity score) find a difference of 4.4 to 4.6 days. The characteristics of the methods are discussed, but it is not possible to know which one is true. However the raw difference seems to overestimate the truth. This methodological bias is quite frequent and is a challenge in public health, as it participates in false knowledge discovery, which could lead decision makers to focus on wrong issues and make wrong decisions.

Entities:  

Mesh:

Year:  2015        PMID: 25991272

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  4 in total

1.  Healthcare resource utilisation and cost associated with elevated potassium levels: a Danish population-based cohort study.

Authors:  Kun Kim; Reimar Wernich Thomsen; Sia Kromann Nicolaisen; Lars Pål Hasvold; Eirini Palaka; Henrik Toft Sørensen
Journal:  BMJ Open       Date:  2019-04-01       Impact factor: 2.692

2.  Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan.

Authors:  Eiichiro Kanda; Naoki Kashihara; Shun Kohsaka; Suguru Okami; Toshitaka Yajima
Journal:  Kidney Med       Date:  2020-10-17

3.  The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland.

Authors:  Thomas Ward; Tray Brown; Ruth D Lewis; Melodi Kosaner Kliess; Antonio Ramirez de Arellano; Carol M Quinn
Journal:  Pharmacoecon Open       Date:  2022-08-04

4.  The Cost of Hyperkalemia in the United States.

Authors:  Keith A Betts; J Michael Woolley; Fan Mu; Cheryl Xiang; Wenxi Tang; Eric Q Wu
Journal:  Kidney Int Rep       Date:  2017-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.